Time on boards
- Boards served
- 3
- Current seats
- 3
- Board service
- 10 years
- Director since
- 2023
10 years of board service in total across 3 boards, counting each seat separately. Longest: Vericel Corporation, 3 years.
Vericel Corporation
Director
Akebia Therapeutics Inc.
Director
SCYNEXIS Inc.
Director
Insider trades
All notable trades →From SEC Forms 4 and 5. Open-market purchases and sales are highlighted; grants, option exercises and shares withheld for tax are routine.
| Date | Company | Transaction | Shares | Price | Value |
|---|---|---|---|---|---|
| Jun 26, 2025 | SCYNEXIS Inc. | Grant or award | +23,000 | — | — |
| Jun 10, 2025 | Akebia Therapeutics Inc. | Grant or award | +35,700 | — | — |
| Oct 16, 2024 | Vericel Corporation | Option exercise | +5,833 | $13.05 | $76,121 |
| Oct 16, 2024 | Vericel Corporation | Open-market sale | −5,833 | $41.36 | $241,253 |
| Oct 2, 2024 | Vericel Corporation | Option exercise | +5,833 | $13.05 | $76,121 |
| Oct 2, 2024 | Vericel Corporation | Open-market sale | −5,833 | $40.35 | $235,362 |
| Sep 18, 2024 | Vericel Corporation | Option exercise | +5,834 | $13.05 | $76,134 |
| Sep 18, 2024 | Vericel Corporation | Open-market sale | −5,834 | $45.54 | $265,680 |
| Sep 4, 2024 | Vericel Corporation | Option exercise | +5,000 | $3.74 | $18,700 |
| Sep 4, 2024 | Vericel Corporation | Open-market sale | −5,000 | $48.58 | $242,900 |
| Jun 20, 2024 | SCYNEXIS Inc. | Grant or award | +23,000 | — | — |
| Jun 6, 2024 | Akebia Therapeutics Inc. | Grant or award | +30,000 | — | — |
| May 1, 2024 | Vericel Corporation | Option exercise | +3,200 | — | — |
| Jun 15, 2023 | SCYNEXIS Inc. | Grant or award | +10,000 | — | — |
| Jun 6, 2023 | Akebia Therapeutics Inc. | Grant or award | +30,000 | — | — |
Reviews (0)
Sign in to write a review.
No reviews yet. Be the first to write one.